PT - JOURNAL ARTICLE ED - , TI - Deletion of LATS1/2 Hippo Pathway Kinases Enhances Antitumor Immunity AID - 10.1158/2159-8290.CD-RW2016-236 DP - 2017 Feb 01 TA - Cancer Discovery PG - OF8--OF8 VI - 7 IP - 2 4099 - http://cancerdiscovery.aacrjournals.org/content/7/2/OF8.short 4100 - http://cancerdiscovery.aacrjournals.org/content/7/2/OF8.full SO - Cancer Discov2017 Feb 01; 7 AB - LATS1/2 loss enhances tumor immunogenicity to promote antitumor immune responses and tumor regression.